Methotrexate as a Promising Treatment for Immune Thrombocytopenia
Abstract
Immune thrombocytopenia either primary or secondary to other diseases may be life threatening especially in cases resistant to the usual treatment regimens. I present here several, among many others, life-threatened ITP patients with failed treatment modalities and a very narrow time window. At this point, we started to use “Methotrexate” as a new treatment modality, not mentioned in the literature before, with excellent results as regard lifesaving and as a complete replacement to other treatments. We are optimistically waiting for the results of a current study to determine the exact efficacy of such modality with very promising results.
Keywords: ITP, Methotrexate, Thrombocytopenia, Systemic lupus erythematosus
Cite this paper: Mohamed N. Al-Alfy, Ahmed Hamdy, Methotrexate as a Promising Treatment for Immune Thrombocytopenia, International Journal of Internal Medicine, Vol. 4 No. 1, 2026, pp. 14-16. doi: 10.5923/j.ijim.20260401.03.
Submit your comment through the following section
